Long-Term Contingent Consideration Payable (Details Textual) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	1 Months Ended			12 Months Ended
	Feb. 29, 2016	Feb. 28, 2013	Mar. 31, 2012	Dec. 31, 2013
Line of Credit Facility [Line Items]
Cash Consideration Received On Royalty Agreement		$ 2,600		$ 2,200
Percentage Of Royalty Payable On Net Sales		1.75%		0.834%
Eclat Pharmaceuticals [Member]
Line of Credit Facility [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			3,300
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right			1,100
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 11.00
Percentage of Earn Out Payments			20.00%
FSC Holdings, LLC [Member]
Line of Credit Facility [Line Items]
Percentage Of Royalty Payable On Net Sales	15.00%
Royalty Amount	$ 12,500
Exercise Price 1 [Member] | Eclat Pharmaceuticals [Member]
Line of Credit Facility [Line Items]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right			2,200
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 7.44